Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-05

Clinical Trial Update: Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating hyperpolarized pyruvate injections in patients with prostate cancer has completed. The update summarizes safety and preliminar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyperpolarized Pyruvate (pyruvate (hyperpolarized, 13C-labeled))

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED